Tinnitus Ear Diseases
Conditions
Interventions
This is a randomized, two-arm, triple-blind clinical trial. A total of 60 participants who meet the eligibility criteria will be allocated to one or the other intervention group using a random number
Sponsors
Instituto Federal do Paraná
Instituto Federal do Paraná
Eligibility
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Volunteers of both genders; aged between 18 and 70 years; clinical diagnosis of persistent tinnitus lasting more than 3 months; with mild to moderate hearing loss; ability to understand and sign the Informed Consent Form
Exclusion criteria
Exclusion criteria: Volunteers with other hearing impairments such as Meniere's disease or neoplasms; those who have undergone any prior treatment for tinnitus in the last 3 months, including laser therapies; those using ototoxic medications or medications that may interfere with tinnitus perception, such as antidepressants; pregnant or breastfeeding women
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the impact of tinnitus on quality of life will be reduced, as assessed by the total score on the Tinnitus Handicap Inventory (THI) questionnaire, by comparing pre-intervention (baseline) and one week post-intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the psychoacoustic characteristics of tinnitus (pitch and loudness) through pre and post-intervention tinnitus assessment;To assess the subjective intensity of tinnitus using the Visual Analogue Scale (VAS), comparing the pre- and post-intervention moments;Assess hearing thresholds using pre and post-intervention tonal and vocal audiometry tests;To assess the condition of the peripheral auditory system using pre- and post-intervention impedance audiometry testing | — |
Countries
BR
Contacts
Public ContactPatricia Oliveira
Instituto Federal do Paranà
Outcome results
None listed